CAMBRIDGE, Mass.--(BUSINESS WIRE)--Molecular Insight Pharmaceuticals, Inc. (NASDAQ: MIPI) announced today that John E. McCray, Chief Operating Officer of Molecular Insight, will participate in a panel discussion on the strategic in-licensing of late-stage compounds at the upcoming Biotechnology Industry Organization (BIO) International Convention, being held June 17-20, 2008 in San Diego, CA. The panel discussion, “Finding the Late-stage Candidate of Your Dreams,” will explore how several companies successfully in-licensed late-stage product candidates from large pharmaceutical companies on terms that were acceptable to management and shareholders and that promised excellent potential returns. This panel will take place on Wednesday, June 18th from 10:15 a.m. to 11:45 a.m. Pacific Time in room 33ABC at the San Diego Convention Center.
